Literature DB >> 20011356

Clostridium difficile colitis.

Judith L Trudel1.   

Abstract

Clostridium difficile enterocolitis is endemic in most modern hospitals. The spectrum of clinical presentation varies from the asymptomatic carrier state to fulminant colitis with toxic megacolon and perforation. Highly toxigenic and lethal strains of C. difficile have emerged worldwide. Medical treatment consists of discontinuing the precipitating antibiotic, supportive measures and bowel rest, and antibiotic treatment with metronidazole or vancomycin. Surgical treatment may be necessary in cases of fulminant disease. Subtotal colectomy with end ileostomy is the operation of choice.

Entities:  

Keywords:  Clostridium difficile; antibiotic-associated colitis; pseudomembranous enterocolitis

Year:  2007        PMID: 20011356      PMCID: PMC2780152          DOI: 10.1055/s-2007-970195

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  33 in total

1.  Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope.

Authors:  S E Persky; L J Brandt
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Outbreak from a high-toxin intruder: Clostridium difficile.

Authors:  Torbjörn Norén
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Pseudomembranous enteritis after proctocolectomy: report of a case.

Authors:  Z Vesoulis; G Williams; B Matthews
Journal:  Dis Colon Rectum       Date:  2000-04       Impact factor: 4.585

Review 4.  Update on Clostridium difficile infection.

Authors:  C S Alcantara; R L Guerrant
Journal:  Curr Gastroenterol Rep       Date:  2000-08

Review 5.  Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding; S Johnson; L R Peterson; M E Mulligan; J Silva
Journal:  Infect Control Hosp Epidemiol       Date:  1995-08       Impact factor: 3.254

Review 6.  Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment.

Authors:  R K Cleary
Journal:  Dis Colon Rectum       Date:  1998-11       Impact factor: 4.585

Review 7.  Clostridium difficile colitis in the critically ill.

Authors:  S Grundfest-Broniatowski; M Quader; F Alexander; R M Walsh; I Lavery; J Milsom
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

8.  Bacterial interference between Clostridium difficile and normal fecal flora.

Authors:  R D Rolfe; S Helebian; S M Finegold
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Pseudomembranous colitis: a surgical disease?

Authors:  P A Lipsett; D K Samantaray; M L Tam; J G Bartlett; K D Lillemoe
Journal:  Surgery       Date:  1994-09       Impact factor: 3.982

10.  Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.

Authors:  R Viscidi; S Willey; J G Bartlett
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  6 in total

Review 1.  Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.

Authors:  John C O'Horo; Amy Jones; Matthew Sternke; Christopher Harper; Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

2.  Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study.

Authors:  N Eliakim-Raz; G Fishman; D Yahav; E Goldberg; G Y Stein; H B Zvi; A Barsheshet; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-17       Impact factor: 3.267

Review 3.  Clostridium difficile Infection and Fecal Microbiota Transplant.

Authors:  Alyssa Liubakka; Byron P Vaughn
Journal:  AACN Adv Crit Care       Date:  2016-07

4.  Direct Detection and Quantification of Bacterial Genes Associated with Inflammation in DNA Isolated from Stool.

Authors:  Ramón Gómez-Moreno; Iraida E Robledo; Abel Baerga-Ortiz
Journal:  Adv Microbiol       Date:  2014-11

5.  Making life difficult for Clostridium difficile: augmenting the pathogen's metabolic model with transcriptomic and codon usage data for better therapeutic target characterization.

Authors:  Sara Saheb Kashaf; Claudio Angione; Pietro Lió
Journal:  BMC Syst Biol       Date:  2017-02-16

6.  Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients.

Authors:  Carla Kuon; Rae Wannier; David Sterken; Margaret C Fang; Jeffrey Wolf; Priya A Prasad
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.